Options Update: Barr Pharm (BRL)
Barr Pharm (BRL)
BRL Volatility Increases As Shares Sell Off 19%
BRL, a global specialty pharmaceutical company, is recently down $9.91 to $39.86 after reporting weak Q1 results.
BRL June option implied volatility of 34 is above its 26-week average of 28, suggesting larger directional risk.
View Paul Foster's post archive >